⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VNRX News
VolitionRX Limited Common Stock
Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference
prnewswire.com
VNRX
Volition Announces Detection of Over 95% of Early-Stage Cancers
prnewswire.com
VNRX
Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
prnewswire.com
VNRX
Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems
prnewswire.com
VNRX
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Volition Announces the Appointment of New Distributor for Nu.Q® Discover
prnewswire.com
VNRX
VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
prnewswire.com
VNRX
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
prnewswire.com
VNRX
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication
prnewswire.com
VNRX